FDA expands COVID-19 testing options via spun synthetic swabs
The Food and Drug Administration yesterday announced that spun synthetic swabs made from materials like polyester can be used for test patients for COVID-19.
FDA based its decision on a clinical investigation that revealed that synthetic swabs can be used for front-of-the-nose testing, which is considered more comfortable for patients, allows for self-testing and limits health care providers’ exposure. To support this declaration, U.S. Cotton says it will produce these new polyester swabs in large quantities to help meet coronavirus diagnostic testing needs.
Related News Articles
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
A CDC study released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…